Kosen
Biosciences About
Kosen Biosciences Kosan uses its proprietary technologies
to develop drug candidates from an important class of natural product compounds
known as polyketides. Polyketides are a rich source of many pharmaceuticals, including
antibiotics (e.g., Zithromax, Biaxin, erythromycin and tetracyclines), anticancer
drugs (e.g., doxorubicin), cholesterol-lowering drugs (e.g., Zocor, Mevacor and
Pravachol), immunosuppressants (e.g., FK506 and rapamycin) and other therapeutics.
Currently Kosan Biosciences is conducting Clinical Trials in the following
indications: •
Solid tumors •
Multiple Myeloma •
Chronic Myeloid Leukemia • Breast
Cancer • Prostate
Cancer More
on Kosen Biosciences Key
Statistics for Kosen
Basic
Chart for Kosen